Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
ATP-sensitive potassium channelopathies: focus on insulin secretion Ashcroft FMJ Clin Invest 2005[Aug]; 115 (8): 2047-58ATP-sensitive potassium (K(ATP)) channels, so named because they are inhibited by intracellular (ATP), play key physiological roles in many tissues. In pancreatic beta cells, these channels regulate glucose-dependent insulin secretion and serve as the target for sulfonylurea drugs used to treat type 2 diabetes. This review focuses on insulin secretory disorders, such as congenital hyperinsulinemia and neonatal diabetes, that result from mutations in K(ATP) channel genes. It also considers the extent to which defective regulation of K(ATP) channel activity contributes to the etiology of type 2 diabetes.|ATP-Binding Cassette Transporters/genetics/*metabolism[MESH]|Animals[MESH]|Diabetes Mellitus, Type 2/drug therapy/genetics/*metabolism[MESH]|Humans[MESH]|Hyperinsulinism/genetics/*metabolism[MESH]|Insulin Secretion[MESH]|Insulin/*metabolism[MESH]|Islets of Langerhans/*metabolism[MESH]|KATP Channels[MESH]|Potassium Channels, Inwardly Rectifying/genetics/*metabolism[MESH]|Sulfonylurea Compounds/therapeutic use[MESH] |
